GGrantIndex
Sort

326,823 grants matching clinical trial

Univ.of Calif., Irvine Cancer Center Support Grant

$2,617,401
University Of California Irvine · P30 · FY2003 · CA

Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Study

$2,615,000
Harold I Feldman · University Of Pennsylvania · U01 · FY2013 · DK

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$2,614,814
David S Stephens · Emory University · UL1 · FY2009 · RR

Vaccine and Treatment Evaluation Units (VTEU)

$2,614,800
Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2021 · AI

The National Drug Abuse Treatment Clinical Trials Network

$2,614,624
Walter Nmn Ling · University Of California Los Angeles · U10 · FY2014 · DA

Flow Cytometry Core

$2,613,776
Stephen Perfetto · National Institute Of Allergy And Infectious Diseases · ZIC · FY2019 · AI

HIV/AIDS Clinical Trials Unit

$2,613,765
John A Bartlett · Duke University · UM1 · FY2012 · AI

CANCER CENTER SUPPORT GRANT

$2,613,676
Gerold Bepler · Wayne State University · P30 · FY2021 · CA

Systemic Autoimmunity

$2,613,591
Mariana Kaplan · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2019 · AR

Data Coordinating Center for the Collaborative Pediatric Critical Care

$2,613,572
Jonathan Michael Dean · University Of Utah · U01 · FY2013 · HD

Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.

$2,613,084
Theodore S Hong · Massachusetts General Hospital · P01 · FY2024 · CA

Translational Research in Breast Cancer

$2,612,827
C Kent Osborne · Baylor College Of Medicine · P50 · FY2007 · CA

Benefits and Harms of Antihypertensive Management Strategies for Nursing Home Residents with ADRD

$2,612,229
Daniel Harris · University Of Delaware · RF1 · FY2025 · AG

Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy

$2,612,197
Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2016 · CA

Genetic Variants, Epigenome and Retinal Disease Phenotypes

$2,612,187
Anand Swaroop · National Eye Institute · ZIA · FY2017 · EY

Radiosurgery vs lobectomy for temporal lobe epilepsy: Phase 3 Clinical Trial

$2,612,182
Nicholas M Barbaro · University Of California, San Francisco · U01 · FY2010 · NS

Radiosurgery vs lobectomy for temporal lobe epilepsy: Phase 3 Clinical Trial

$2,612,182
Nicholas M Barbaro · University Of California, San Francisco · U01 · FY2010 · NS

Lifespan/Tufts/brown Center for AIDS Research (CFAR)

$2,612,007
Charles Cj Carpenter · Miriam Hospital · P30 · FY2014 · AI

Community Ambulation Following Hip Fracture

$2,611,644
Jay Steven Magaziner · University Of Maryland Baltimore · R01 · FY2011 · AG

Emergency Department Safety Assessment and Follow-Up Evaluation (EDSAFE) Trial

$2,611,585
Edwin D Boudreaux · Univ Of Massachusetts Med Sch Worcester · U01 · FY2011 · MH

Cancer Center Support Grant - P30

$2,611,363
University Of California Davis · P30 · FY2005 · CA

Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes

$2,610,804
Andrew Scott Weyrich · University Of Utah · U54 · FY2014 · HL

Interdisciplinary Comprehensive Arm Rehab Evaluation (I-CARE) Stroke Initiative

$2,610,796
Carolee J Winstein · University Of Southern California · U01 · FY2011 · NS

Wake forest Clinical and Translational Science Award

$2,610,385
Donald A. McClain · Wake Forest University Health Sciences · UL1 · FY2017 · TR

Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders

$2,610,373
Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL